In CD8+ T cells, it has been identified LIMIT (lncRNA Inducing MHC-I and Immunogenicity of Tumor) is a novel immunogenic lncRNA, which is sensitive to IFN-γ. This evidence concerns the gene IFNG and neoplasm.